Results 231 to 240 of about 831,586 (304)
Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors. [PDF]
World J Surg OncolHu H, Lei D, Liang Y.
europepmc +1 more source
Avatrombopag for the salvage treatment of platelet transfusion refractoriness. [PDF]
Ther Adv HematolQin Y, Wang Y, Zhang Y, Jiao Y, Ye J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood Reviews, 2023
Platelet transfusion refractoriness due HLA alloimmunization presents a significant medical problem, particularly among multiply transfused patients with hematologic malignancies and those undergoing hematopoietic stem cell transplants.
Ralph Vassallo
exaly +2 more sources
Platelet transfusion refractoriness due HLA alloimmunization presents a significant medical problem, particularly among multiply transfused patients with hematologic malignancies and those undergoing hematopoietic stem cell transplants.
Ralph Vassallo
exaly +2 more sources
Platelet transfusion: Alloimmunization and refractoriness
Seminars in Hematology, 2020The transfusion of platelets for both prophylaxis and treatment of bleeding is relevant to all areas of medicine and surgery. Historically, guidance regarding platelet transfusion has been limited by a lack of good quality clinical trials and so has been
Michael Murphy +2 more
exaly +2 more sources
Hematology/Oncology Clinics of North America, 2013
Platelet transfusion therapy has become an integral part of the treatment of patients with hematological and solid tumor malignancy receiving chemotherapy. Since its introduction almost 60 years ago, several advances and refinements have been introduced in the collection, storage, and administration to improve the safety and efficacy of platelet ...
Perumal Thiagarajan +1 more
exaly +3 more sources
Platelet transfusion therapy has become an integral part of the treatment of patients with hematological and solid tumor malignancy receiving chemotherapy. Since its introduction almost 60 years ago, several advances and refinements have been introduced in the collection, storage, and administration to improve the safety and efficacy of platelet ...
Perumal Thiagarajan +1 more
exaly +3 more sources
Platelet transfusion refractoriness and anti‐HLA immunization
Transfusion, 2021Platelet transfusion refractoriness (PTR), defined as an unsatisfactory post‐transfusion platelet count increment, is a common complication of patients receiving multiple transfusions. Different strategies are described in the management of PTR.
Lucie Blandin +7 more
semanticscholar +1 more source
Platelet Transfusion: An Update on Indications and Guidelines.
Clinics in Laboratory Medicine, 2021Platelets are commonly transfused either therapeutically or prophylactically to maintain hemostasis. Most platelet transfusions are used to manage patients with hematologic malignancies.
Shan Yuan, Z. Otrock
semanticscholar +1 more source
GUIDELINES FOR THE TRANSFUSION OF PLATELETS
Acta Clinica Belgica, 2007Recommendations aiming at standardising and rationalising clinical indications for the transfusion of platelets in Belgium were drawn up by a working group of the Superior Health Council. To this end the Superior Health Council organised an expert meeting devoted to "Guidelines for the transfusion of platelets" in collaboration with the Belgian ...
Bosly, André +9 more
openaire +4 more sources
Optimizing platelet transfusions
Current Opinion in Hematology, 2015Platelet transfusion remains a challenging procedure. Concerns about bacterial contamination and other complications, and the interest in improving the evidence base for criteria for platelet transfusion thresholds and policies have provided impetus for studies that challenge the status quo.
Kyle, Annen, Jordan E, Olson
openaire +2 more sources